Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-25 @ 4:36 PM
Study NCT ID:
NCT01939457
Status:
COMPLETED
Last Update Posted:
2013-09-11
First Post:
2013-08-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
400mcg Sublingual Misoprostol as First Line Treatment
Sponsor:
Gynuity Health Projects
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-07
First Submit QC Date:
None
Study First Post Date:
2013-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-06
Last Update Post Date:
2013-09-11
Last Update Post Date Type:
ESTIMATED